Provider intervention associated with usage decline of high risk meds

Intervention impacts use of high-risk drugs in CMS Star metric

September 21, 2017

Intervention designed to impact use of high-risk medications evaluated as part of CMS Star metric

Prime sent letters to doctors to let them know they had prescribed high-risk medications to Medicare members. The intervention group’s high-risk medication percentage declined more than the control group. It was a statistically significant difference. Certain medications carry a greater risk of adverse events for the older adults than for younger people. Safer options exist for many high-risk medications.

Impact of First Fill Intervention on High-risk Medication Usage in a One Million Member Medicare Population (Fall 2016)

Related news

Perspectives

July 16, 2024

LISTEN NOW: Beyond the business – Stories of corporate kindness | Pharmacy Friends Podcast

In this episode, we talk about how our employees' help goes beyond our work in health care, aiding in philanthropic efforts

Perspectives

July 12, 2024

August 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market

Perspectives

July 12, 2024

High-Cost Therapy Profile: July 2024

Detailed information about Afamitresgene autoleucel Intravenous (IV)